Preservation of Helicobacter pylori CagA Translocation and Host Cell Proinflammatory Responses in the Face of CagL Hypervariability at Amino Acid Residues 58/59

PLoS One. 2015 Jul 21;10(7):e0133531. doi: 10.1371/journal.pone.0133531. eCollection 2015.

Abstract

Carriage of the CagA oncoprotein by the human gastric cancer-associated pathogen Helicobacter pylori is significantly associated with this typically benign chronic infection advancing to a potentially fatal outcome. However it remains to be elucidated why only a small subset of individuals infected with H. pylori CagA-positive strains develops gastric cancer. H. pylori translocates CagA into host cells using a type IV secretion apparatus that interacts with host integrin receptors via a three-amino-acid-residue RGD motif on the H. pylori protein CagL. The RGD motif of CagL also plays a major role in the induction of proinflammatory responses. Upstream of this motif is a conserved glycine flanked by four hypervariable amino acid residues (residues 58, 59, 61 and 62). Certain amino acid polymorphisms at 58 and 59 are significantly prevalent in strains from gastric cancer patients in particular geographic regions; Y58E59 is seen in Taiwan and D58K59 in India. In light of the seemingly contradictory findings of recent CagL mutagenesis studies, we have examined the contribution of sequence promiscuity specifically at CagL residues 58 and 59 to CagA translocation and H. pylori-mediated proinflammatory responses of gastric epithelial cells. Using isogenic mutants of H. pylori strains P12 and 26695 with amino acid substitutions at CagL residues 58 and 59, we determined that carriage of the polymorphisms Y58E59, D58K59, D58E59, N58E59 or N58K59 did not significantly alter the capacity of H. pylori to translocate CagA into, or induce IL-8 secretion in, host cells. Our findings, together with other recently published data, suggest that the variation at CagL residues 58 and 59 does not influence type IV secretion system function in isolation, but rather may work in concert with particular polymorphisms elsewhere in CagL to modulate disease progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution*
  • Antigens, Bacterial / genetics*
  • Bacterial Proteins / genetics*
  • Cell Line, Tumor
  • Epithelial Cells / metabolism
  • Epithelial Cells / microbiology
  • Helicobacter pylori / genetics*
  • Helicobacter pylori / pathogenicity
  • Humans
  • Inflammation / metabolism
  • Inflammation / microbiology
  • Interleukin-8 / metabolism
  • Polymorphism, Single Nucleotide
  • Translocation, Genetic*
  • Type IV Secretion Systems / metabolism

Substances

  • Antigens, Bacterial
  • Bacterial Proteins
  • Interleukin-8
  • Type IV Secretion Systems
  • cagA protein, Helicobacter pylori
  • cagF protein, Helicobacter pylori

Grants and funding

TK was supported by National Health and Medical Research Council Australia project grant 545983, and the Monash University Research Accelerator Program Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.